Bellaire Dialysis in Sugar Land, Texas - Dialysis Center

Bellaire Dialysis is a medicare approved dialysis facility center in Sugar Land, Texas and it has 15 dialysis stations. It is located in Fort Bend county at 14412 Bellaire Blvd., Sugar Land, TX, 77478. You can reach out to the office of Bellaire Dialysis at (281) 575-8000. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Bellaire Dialysis has the following ownership type - Profit. It was first certified by medicare in April, 2017. The medicare id for this facility is 672806 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBellaire Dialysis
Location14412 Bellaire Blvd., Sugar Land, Texas
No. of Dialysis Stations 15
Medicare ID672806
Managed ByIndependent
Ownership TypeProfit
Late Shifts No

Contact Information


14412 Bellaire Blvd., Sugar Land, Texas, 77478
(281) 575-8000
Not Available

News Archive

Sexually transmitted infection epidemic worries health experts

Researchers at the University of New South Wales (NSW) revealed that new cases of gonorrhea and Chlamydia are on the rise in Australia, particularly among young members of indigenous communities.

New finding in studying dopamine transporter

Confirming findings in a previous study, Yale researchers observed an altered availability of the dopamine transporter in healthy persons with a genetic variation linked to substance abuse and attention deficit hyperactivity disorder (ADHD).

4-in-1 influenza vaccine appears to provide broad protection against flu

A vaccine combining centralized ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, according to new research by a team from the Nebraska Center for Virology.

Leading public health experts agree: Menthol ban could save thousands of lives

Today, as the U.S. Food and Drug Administration continues to weigh a potential menthol ban, the American Academy of Pediatrics, American Public Health Association, Center for American Progress and Legacy called for menthol cigarettes to be taken off the market, citing key findings published today in the American Journal of Public Health.

Abbott commences elagolix Phase 3 trial in endometriosis

Abbott, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis.

Read more Medical News

› Verified 7 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bellaire Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1376086058
Doing Business AsPost Oak Dialysis & Kidney Center
Address13211 S. Post Oak Rd Houston, Texas, 77045
Phone Number(281) 575-8000

News Archive

Sexually transmitted infection epidemic worries health experts

Researchers at the University of New South Wales (NSW) revealed that new cases of gonorrhea and Chlamydia are on the rise in Australia, particularly among young members of indigenous communities.

New finding in studying dopamine transporter

Confirming findings in a previous study, Yale researchers observed an altered availability of the dopamine transporter in healthy persons with a genetic variation linked to substance abuse and attention deficit hyperactivity disorder (ADHD).

4-in-1 influenza vaccine appears to provide broad protection against flu

A vaccine combining centralized ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, according to new research by a team from the Nebraska Center for Virology.

Leading public health experts agree: Menthol ban could save thousands of lives

Today, as the U.S. Food and Drug Administration continues to weigh a potential menthol ban, the American Academy of Pediatrics, American Public Health Association, Center for American Progress and Legacy called for menthol cigarettes to be taken off the market, citing key findings published today in the American Journal of Public Health.

Abbott commences elagolix Phase 3 trial in endometriosis

Abbott, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis.

Read more Medical News

› Verified 7 days ago


NPI Number1598168817
Doing Business AsBellaire Dialysis
Address14412 Bellaire Blvd Houston, Texas, 77083
Phone Number(713) 634-9818

News Archive

Sexually transmitted infection epidemic worries health experts

Researchers at the University of New South Wales (NSW) revealed that new cases of gonorrhea and Chlamydia are on the rise in Australia, particularly among young members of indigenous communities.

New finding in studying dopamine transporter

Confirming findings in a previous study, Yale researchers observed an altered availability of the dopamine transporter in healthy persons with a genetic variation linked to substance abuse and attention deficit hyperactivity disorder (ADHD).

4-in-1 influenza vaccine appears to provide broad protection against flu

A vaccine combining centralized ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, according to new research by a team from the Nebraska Center for Virology.

Leading public health experts agree: Menthol ban could save thousands of lives

Today, as the U.S. Food and Drug Administration continues to weigh a potential menthol ban, the American Academy of Pediatrics, American Public Health Association, Center for American Progress and Legacy called for menthol cigarettes to be taken off the market, citing key findings published today in the American Journal of Public Health.

Abbott commences elagolix Phase 3 trial in endometriosis

Abbott, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis.

Read more Medical News

› Verified 7 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data1

News Archive

Sexually transmitted infection epidemic worries health experts

Researchers at the University of New South Wales (NSW) revealed that new cases of gonorrhea and Chlamydia are on the rise in Australia, particularly among young members of indigenous communities.

New finding in studying dopamine transporter

Confirming findings in a previous study, Yale researchers observed an altered availability of the dopamine transporter in healthy persons with a genetic variation linked to substance abuse and attention deficit hyperactivity disorder (ADHD).

4-in-1 influenza vaccine appears to provide broad protection against flu

A vaccine combining centralized ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, according to new research by a team from the Nebraska Center for Virology.

Leading public health experts agree: Menthol ban could save thousands of lives

Today, as the U.S. Food and Drug Administration continues to weigh a potential menthol ban, the American Academy of Pediatrics, American Public Health Association, Center for American Progress and Legacy called for menthol cigarettes to be taken off the market, citing key findings published today in the American Journal of Public Health.

Abbott commences elagolix Phase 3 trial in endometriosis

Abbott, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis.

Read more Medical News

› Verified 7 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center5
    Adult patient months included in Kt/V greater than or equal to 1.223
    Percentage of adult patients getting regular hemodialysis at the center
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Sexually transmitted infection epidemic worries health experts

    Researchers at the University of New South Wales (NSW) revealed that new cases of gonorrhea and Chlamydia are on the rise in Australia, particularly among young members of indigenous communities.

    New finding in studying dopamine transporter

    Confirming findings in a previous study, Yale researchers observed an altered availability of the dopamine transporter in healthy persons with a genetic variation linked to substance abuse and attention deficit hyperactivity disorder (ADHD).

    4-in-1 influenza vaccine appears to provide broad protection against flu

    A vaccine combining centralized ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, according to new research by a team from the Nebraska Center for Virology.

    Leading public health experts agree: Menthol ban could save thousands of lives

    Today, as the U.S. Food and Drug Administration continues to weigh a potential menthol ban, the American Academy of Pediatrics, American Public Health Association, Center for American Progress and Legacy called for menthol cigarettes to be taken off the market, citing key findings published today in the American Journal of Public Health.

    Abbott commences elagolix Phase 3 trial in endometriosis

    Abbott, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis.

    Read more Medical News

    › Verified 7 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bellaire Dialysis with elevated calcium levels.

Patients with hypercalcemia5
Hypercalcemia patient months23
Hypercalcemia patients with serumcalcium greater than 10.2 mg
Patients with Serumphosphor10
Patients with Serumphosphor less than 3.5 mg/dL
Patients with Serumphosphor from 3.5 to 4.5 mg/dL
Patients with Serumphosphor from 4.6 to 5.5 mg/dL
Patients with Serumphosphor from 5.6 to 7 mg/dL
Patients with Serumphosphor greater than 7 mg/dL

News Archive

Sexually transmitted infection epidemic worries health experts

Researchers at the University of New South Wales (NSW) revealed that new cases of gonorrhea and Chlamydia are on the rise in Australia, particularly among young members of indigenous communities.

New finding in studying dopamine transporter

Confirming findings in a previous study, Yale researchers observed an altered availability of the dopamine transporter in healthy persons with a genetic variation linked to substance abuse and attention deficit hyperactivity disorder (ADHD).

4-in-1 influenza vaccine appears to provide broad protection against flu

A vaccine combining centralized ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, according to new research by a team from the Nebraska Center for Virology.

Leading public health experts agree: Menthol ban could save thousands of lives

Today, as the U.S. Food and Drug Administration continues to weigh a potential menthol ban, the American Academy of Pediatrics, American Public Health Association, Center for American Progress and Legacy called for menthol cigarettes to be taken off the market, citing key findings published today in the American Journal of Public Health.

Abbott commences elagolix Phase 3 trial in endometriosis

Abbott, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis.

Read more Medical News

› Verified 7 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 6
Patient months included in arterial venous fistula and catheter summaries 14
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer

News Archive

Sexually transmitted infection epidemic worries health experts

Researchers at the University of New South Wales (NSW) revealed that new cases of gonorrhea and Chlamydia are on the rise in Australia, particularly among young members of indigenous communities.

New finding in studying dopamine transporter

Confirming findings in a previous study, Yale researchers observed an altered availability of the dopamine transporter in healthy persons with a genetic variation linked to substance abuse and attention deficit hyperactivity disorder (ADHD).

4-in-1 influenza vaccine appears to provide broad protection against flu

A vaccine combining centralized ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, according to new research by a team from the Nebraska Center for Virology.

Leading public health experts agree: Menthol ban could save thousands of lives

Today, as the U.S. Food and Drug Administration continues to weigh a potential menthol ban, the American Academy of Pediatrics, American Public Health Association, Center for American Progress and Legacy called for menthol cigarettes to be taken off the market, citing key findings published today in the American Journal of Public Health.

Abbott commences elagolix Phase 3 trial in endometriosis

Abbott, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis.

Read more Medical News

› Verified 7 days ago